[Correction of immune response using purified staphylococcal toxoid and likopid in the secondary immunodeficiency induced by Coxsackie virus B3].
The action of immunomodulators, purified staphylococcal toxoid (PST) and lycopid, on secondary immunodeficiency state developing during infection caused by Coxsackie virus B3 was studied. This defect was manifested by delayed hypersensitivity to sheep red blood cells (SRBC) and the suppression of neutralizing antibodies to poliomyelitis virus. Depending on the scheme of the experiment, PST normalized the defects of immune response to SRBC or poliovirus, increased suppression or showed no activity. Lycopid corrected the defects of humoral response to SRBC. The combination of PST and lycopid was found to produce no increase of suppression. The suggestion was made on the expediency of combination of two (and probably more) immunomodulators for increasing the efficiency of correction of secondary immunodeficiency.
Semenova
I B
IB
Gamaleya Research Institute of Epidemiology and Microbiology, Chumakov Research Institute of Poliomyelitis and Viral Encephalitis, Moscow, Russia.
Vasil'eva
I G
IG
Akatov
A K
AK
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000276:immunology*; D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D029822:Enterovirus B, Human; D004769:Enterovirus Infections / Q000276:immunology*; D007109:Immunity / Q000276:immunology*; D007165:Immunosuppression Therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D008808:Mice, Inbred CBA; D008811:Mice, Inbred DBA; D013208:Staphylococcal Toxoid / Q000008:administration & dosage / Q000276:immunology*
D000276:Adjuvants, Immunologic; D013208:Staphylococcal Toxoid; C089161:glikopin; D000119:Acetylmuramyl-Alanyl-Isoglutamine